High-intensity Functional Training on Functional and Cognitive Performance in People with Parkinson's Disease.

Parkinson's disease (PD) is a progressive and chronic neurodegenerative disease, which presents signs and symptoms both motor (impaired gait, posture, balance, etc.) and cognitive (memory loss, dementia, etc.), all of which are causing disability and assuming a high economic cost. Currently, there are already certain authors who have shown how a high-intensity interval training (HIIT) protocol produces improvements in cognitive and physical performance in healthy adults6 and in people with multiple sclerosis. However, another modality has been created, such as high-intensity functional training (HIFT), which can benefit different populations, both healthy and pathological, due to the multimodal nature of the exercises. Thanks to multimodality, more aspects such as agility, coordination and precision of movements are worked on compared to unimodal HIIT programs that make this relevant work difficult in a person's daily life. The current study aims to demonstrate the effectiveness of a HIFT training protocol in a specific population, such as people with Parkinson's disease.

Study identifier: NCT06879821. Status: RECRUITING. Phase: NA.

Eligibility

Criteria: Inclusion Criteria: * Diagnosis of Parkinson's disease. * Stage I or II (Hoehn - Yahr Scale). * Age between 45 and 80 years. * Independent ambulation for 10 consecutive minutes. * Regular physical exercise. Exclusion Criteria: * Medical contraindication for physical activity, deafness or limited hearing and very low vision or blind. * Vestibular disorders that compromise balance. * Psychotic or severe cognitive disorder. * Decompensation or changes in medication. * Surgical intervention in the last 6 months. * Sedentary persons

  • Minimum age: 40 Years
  • Maximum age: 80 Years

Participating locations

  • University of Valencia, Valencia, Valencia

Study records are sourced from ClinicalTrials.gov. Confirm current eligibility, recruiting status, and locations in the official record.

View the official ClinicalTrials.gov record for NCT06879821

Browse Parkinson's clinical trials